Psychobiological Mechanisms of Placebo and Nocebo Effects in the Treatment of Chronic Back Pain
1 other identifier
interventional
80
1 country
1
Brief Summary
Placebo and nocebo responses have mainly been studied in healthy humans for pharmacological rather than psychological interventions. Moreover, only few studies examined patients or tested how previous experience and attitudes affect placebo and nocebo responses. On the psychological level expectancy and classical conditioning have been identified as two primary mechanisms. Both seem to be important with classical conditioning potentially having more long-term effects and expectancy being more important in nocebo effects. There is some initial evidence from the investigators own research that patients may be more prone to these effects and the investigators have also shown that placebo effects may last up to several years after treatment. The investigators therefore examine previous attitudes to pharmacological interventions for chronic pain in patients with chronic back pain and subdivide them into groups with high of low belief in the respective treatment modality. The investigators then apply a pharmacological placebo and study the interaction between the prevailing attitude (implicit and explicit) and the placebo effect with respect to pain perception but also to neurobiological mechanisms using functional magnetic resonance imaging. In addition to expectancy, conditioning of placebo will be examined and the long-term effects of the intervention will be determined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 3, 2014
CompletedFirst Posted
Study publicly available on registry
June 6, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedJanuary 16, 2015
January 1, 2015
2.4 years
June 3, 2014
January 15, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in pain intensity and pain unpleasantness ratings after placebo intervention
immediatey to one week
Secondary Outcomes (2)
Changes in neuronal activity in response to painful stimulation after placebo administration
immediately
Changes in movement abilities after placebo administration
immediately to one week
Study Arms (1)
placebo
EXPERIMENTALAdministration of a pharmacological placebo (sodium chloride) via transdermal application to investigate the influence on pain perception in chronic back pain patients and to investigate the influence of attitude and experience with medication on the placebo effect
Interventions
Eligibility Criteria
You may qualify if:
- Male and female human subjects with chronic back pain (chronic persistent and recurrent pain \> 6 months)
- Age between 18 and 65
- Voluntary participation.
You may not qualify if:
- Acute or chronic somatic diseases and inflammatory, neuropathic or tumor-related pain
- Acute and chronic mental disorders according to DSM-IV (except for comorbid anxiety or depression, which are frequent in chronic pain)
- Insufficient German language skills
- Cognitive limitations
- Intake of opioid medication or tranquilizers
- Metal implants or electric implants that cannot be removed
- Pregnancy
- Claustrophobia
- History of epilepsy, brain trauma, or brain tumor
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Central Institute of Mental Health
Mannheim, 68159, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Herta Flor, PhD
Medical Faculty Mannheim, Heidelberg University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. Herta Flor
Study Record Dates
First Submitted
June 3, 2014
First Posted
June 6, 2014
Study Start
July 1, 2012
Primary Completion
December 1, 2014
Study Completion
December 1, 2014
Last Updated
January 16, 2015
Record last verified: 2015-01